C. Lanigan et al., THE EFFECTS OF BETA(2)-AGONISTS AND CAFFEINE ON RESPIRATORY AND LIMB MUSCLE PERFORMANCE, The European respiratory journal, 6(8), 1993, pp. 1192-1196
The possibility that respiratory muscle function may be improved by dr
ug therapy is of clinical importance, but remains controversial. A ser
ies of studies concerning the effects of maximally tolerated dosages o
f terbutaline, tulobuterol (a new beta2-agonist) and caffeine on respi
ratory muscle strength and limb muscle strength and endurance were und
ertaken in normal subjects. Drugs were administered orally, 2 h before
study. Caffeine produced a small but statistically significant increa
se in the stimulated contraction force at 20 Hz, and a small beneficia
l effect on recovery from a fatiguing protocol; maximum voluntary cont
raction force of the quadriceps was increased by 3.8%. Terbutaline and
tulobuterol had no beneficial effects on either respiratory or limb m
uscle function. We conclude that conventional dosages of these broncho
dilator drugs do not greatly affect skeletal muscle performance.